Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Tumors

Explore clinical trials studying Advanced Solid Tumors. Study availability and eligibility vary by location and protocol.

619 public trials 187 recruiting studies
Refine in advanced search Browse all conditions

Advanced Solid Tumors trial results

Recruiting

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

NCT06799065

Conditions
Adnexal Diseases, Advanced Solid Tumors, Breast Cancer Recurrent, +22 more
Locations
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

NCT07360314

Conditions
Adnexal Diseases, Advanced Solid Tumors, Breast Diseases, +29 more
Locations
  • Yale University - Yale University School of Medicine New Haven, Connecticut, United States
  • Carolina BioOncology Institute, LLC - Cancer Therapy and Research Center Huntersville, North Carolina, United States
  • NEXT Houston Galveston, Texas, United States
  • NEXT Oncology - PARENT San Antonio, Texas, United States
View Trial Details
Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

NCT06004245

Conditions
Advanced Solid Tumors, Colonic Diseases, Colorectal Cancer, +14 more
Locations
  • City of Hope Cancer Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • START Los Angeles Los Angeles, California, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
View all 43 locations
View Trial Details
Recruiting

A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

NCT06792552

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumors, +35 more
Locations
  • Sarah Cannon Research Institute (SCRI) - Lake Nona Orlando, Florida, United States
  • Emory Winship Cancer Institute Atlanta, Georgia, United States
  • University Medical Center of New Orleans LSU-LCMC Health Cancer Center New Orleans, Louisiana, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 17 locations
View Trial Details
Recruiting

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

NCT06657222

Conditions
Advanced Solid Tumors, Breast Diseases, Breast Neoplasms, +16 more
Locations
  • Yale Cancer Center New Haven, Connecticut, United States
  • University of Miami Miami, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
View all 18 locations
View Trial Details
Recruiting

A Phase I Study of CS5007 in Participants With Advanced Solid Tumors

NCT07622524

Conditions
Advanced Solid Tumors
Locations
  • St Vincent's Hospital Sydney Darlinghurst, New South Wales, Australia
  • Macquarie University North Ryde, New South Wales, Australia
  • Icon Cancer Centre South Brisbane South Brisbane, Queensland, Australia
  • St Vincent's Hospital Melbourne Fitzroy, Victoria, Australia
View Trial Details
Recruiting

A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors

NCT07266428

Conditions
Advanced Solid Tumors
Locations
  • Yale Cancer Center New Haven, Connecticut, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids, Michigan, United States
  • South Texas Accelerated Research Therapeutics (START) San Antonio, Texas, United States
View all 14 locations
View Trial Details
Recruiting

Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors

NCT06384352

Conditions
Advanced Solid Tumors
Locations
  • University of Colorado Hospital - Anschutz Cancer Pavilion Aurora, Colorado, United States
  • Sarah Cannon Research Institute (SCRI) at HealthONE Denver, Colorado, United States
  • Yale School of Medicine - Yale Cancer Center - Smilow Cancer Hospital Care Centers - North Haven North Haven, Connecticut, United States
  • Sarah Cannon Research Institute at Florida Cancer Specialists Orlando, Florida, United States
View all 21 locations
View Trial Details

Related conditions